Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Collegium Pharmaceutical
COLL
5
Enerpac Tool
EPAC
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -14.21%21.79M | 119.30%5.99M | -77.77%2.23M | -10.82%5.5M | 24.43%8.07M | 8.81%25.39M | -24.10%2.73M | 27.28%10.01M | -5.13%6.17M | 20.72%6.48M |
Net income from continuing operations | -27.47%5.79M | -61.24%443K | 11.05%2.93M | -0.52%1.73M | -71.98%691K | 44.97%7.98M | 38.71%1.14M | 56.23%2.63M | -17.47%1.74M | 177.39%2.47M |
Operating gains losses | 590.48%309K | ---- | ---- | 65.45%-19K | 118.18%2K | -1,675.00%-63K | ---- | ---- | -1,933.33%-55K | -37.50%-11K |
Depreciation and amortization | 11.42%13.1M | 32.49%3.94M | -6.68%3.02M | 12.07%3.12M | 9.25%3.02M | 16.78%11.76M | 7.51%2.98M | 28.96%3.23M | 13.49%2.78M | 18.14%2.77M |
Deferred tax | -38.47%1.47M | -258.70%-365K | -6.89%1M | 66.48%586K | -65.85%252K | 75.13%2.39M | -72.12%230K | 345.64%1.07M | 134.67%352K | 388.74%738K |
Other non cash items | -784.82%-767K | -110.50%-91K | -4.20%-273K | 16.07%-423K | 81.82%20K | 154.55%112K | 7,781.82%867K | -2,481.82%-262K | -4,681.82%-504K | 0.00%11K |
Change In working capital | -54.94%848K | 152.28%1.59M | -241.13%-4.7M | -87.92%168K | 1,730.92%3.79M | -60.06%1.88M | -90.09%-3.05M | 6.86%3.33M | -19.87%1.39M | -85.83%207K |
-Change in receivables | -99.80%-1.99M | -2,560.71%-1.49M | -764.15%-458K | 24.19%-373K | 185.24%335K | -300.81%-994K | -130.27%-56K | 8.62%-53K | -18.27%-492K | -1,058.54%-393K |
-Change in payables and accrued expense | -44.09%-915K | 44.06%-1.62M | -67.68%604K | -53.54%-1.28M | 12.65%1.38M | 65.30%-635K | 3.47%-2.9M | -25.51%1.87M | 41.05%-833K | 1,555.41%1.23M |
-Change in other current assets | 81.09%565K | 670.65%1.42M | -2.07%-741K | -15.89%-474K | -71.34%362K | -47.74%312K | -81.21%184K | -228.72%-726K | 20.43%-409K | 392.36%1.26M |
-Change in other current liabilities | -0.47%3.18M | 1,269.40%3.29M | -283.19%-4.11M | -26.59%2.29M | 190.73%1.71M | -48.34%3.2M | -221.12%-281K | 2,056.73%2.24M | -23.39%3.13M | -206.19%-1.89M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -14.21%21.79M | 119.30%5.99M | -77.77%2.23M | -10.82%5.5M | 24.43%8.07M | 8.81%25.39M | -24.10%2.73M | 27.28%10.01M | -5.13%6.17M | 20.72%6.48M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -13.57%-32.48M | -252.60%-13.31M | -42.48%-6.96M | 9.88%-6.45M | 54.91%-5.77M | 16.35%-28.6M | 56.89%-3.77M | 54.13%-4.89M | 16.13%-7.15M | -104.45%-12.79M |
Capital expenditure reported | -44.87%-32.32M | -252.25%-13.15M | -42.56%-6.96M | 9.88%-6.45M | 11.91%-5.76M | 34.35%-22.31M | 56.88%-3.73M | 54.29%-4.89M | 15.54%-7.15M | -6.01%-6.54M |
Net business purchase and sale | 97.60%-150K | ---150K | --0 | --0 | --0 | -3,370.00%-6.25M | --0 | --0 | --0 | -7,248.24%-6.25M |
Net other investing changes | 90.00%-4K | ---- | ---- | --0 | ---4K | -66.67%-40K | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -13.57%-32.48M | -252.60%-13.31M | -42.48%-6.96M | 9.88%-6.45M | 54.91%-5.77M | 16.35%-28.6M | 56.89%-3.77M | 54.13%-4.89M | 16.13%-7.15M | -104.45%-12.79M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 4,108.37%17.09M | -93.87%-3.6M | 492.77%7.12M | -197.68%-2.23M | 782.52%15.81M | -91.83%406K | 51.95%-1.86M | -114.31%-1.81M | 171.42%2.29M | 389.34%1.79M |
Net issuance payments of debt | 988.73%15.85M | -794.72%-1.84M | 129.78%2.05M | -234.78%-1.99M | 423.25%17.62M | 50.11%-1.78M | 117.05%265K | -4,461.39%-6.89M | 168.60%1.48M | 12,128.57%3.37M |
Net common stock issuance | --0 | --0 | --0 | ---- | ---- | -81.45%2.75M | --0 | --0 | ---- | ---- |
Cash dividends paid | -1.57%-7.3M | -1.27%-1.84M | -1.22%-1.82M | -1.56%-1.82M | -2.25%-1.82M | -4.30%-7.19M | 0.06%-1.81M | -3.93%-1.8M | -7.17%-1.79M | -6.53%-1.78M |
Net other financing activities | 28.86%8.54M | 123.47%73K | 0.12%6.89M | 1,194.44%1.58M | -99.01%2K | 970.44%6.63M | 26.13%-311K | 1,145.44%6.88M | -123.15%-144K | -81.23%202K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 4,108.37%17.09M | -93.87%-3.6M | 492.77%7.12M | -197.68%-2.23M | 782.52%15.81M | -91.83%406K | 51.95%-1.86M | -114.31%-1.81M | 171.42%2.29M | 389.34%1.79M |
Net cash flow | ||||||||||
Beginning cash position | -37.01%4.76M | 188.04%22.08M | 352.26%19.7M | 649.66%22.87M | -37.01%4.76M | -43.75%7.56M | -53.79%7.67M | -35.15%4.36M | -74.45%3.05M | -43.75%7.56M |
Current changes in cash | 328.40%6.39M | -276.36%-10.92M | -28.04%2.38M | -343.56%-3.18M | 501.44%18.11M | 52.41%-2.8M | 67.85%-2.9M | -66.47%3.31M | 124.96%1.3M | -200.33%-4.51M |
End cash Position | 134.22%11.16M | 134.22%11.16M | 188.04%22.08M | 352.26%19.7M | 649.66%22.87M | -37.01%4.76M | -37.01%4.76M | -53.79%7.67M | -35.15%4.36M | -74.45%3.05M |
Free cash flow | -442.06%-10.54M | -614.26%-7.16M | -192.52%-4.74M | 3.97%-943K | 4,219.64%2.31M | 128.94%3.08M | 80.19%-1M | 281.37%5.12M | 50.00%-982K | 92.98%-56K |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |